The Party and State have always regarded the protection, care, and improvement of public health as a top priority, which has been shown through efforts to design comprehensive legal frameworks and policies to strengthen the healthcare system, particularly in the current era.

The National Assembly (NA) Standing Committee on December 30, 2021 issued a resolution allowing the implementation of a number of mechanisms and policies in the healthcare sector serving COVID-19 prevention and control activities, including the management of drug and drug ingredients.